More intensive monitoring allows earlier detection of recurring colon cancer

Wednesday 3 February 2016

A new type of post-operative check-up for patients treated for colorectal cancer allows for earlier detection of recurrence of the disease. This method involves more frequent blood Continue reading »

More intensive monitoring allows earlier detection of recurring colon cancer

Polyganics' NEUROCAP receives FDA 510 (K) clearance

Friday 29 January 2016

Polyganics announced it has received FDA 510 (K) clearance for NEUROCAP. This is an innovative device, designed to reduce painful neuroma formation. Thereby it facilitates tissue Continue reading »

Polyganics' NEUROCAP receives FDA 510 (K) clearance

Funding for Mucosis for Clinical Trials

Friday 22 January 2016

Mucosis B.V., a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human vaccines for infectious diseases, today Continue reading »

Funding for Mucosis for Clinical Trials

New patent granted to Diagnoptics in Japan and EU

Thursday 7 January 2016

Diagnoptics announces that it has been granted a Japan and EU patent for a method for skin colour independent assessment of Advanced Glycation Endproducts. A method for skin Continue reading »

New patent granted to Diagnoptics in Japan and EU

Glazed frost and its consequences for the UMCG on Campus

Thursday 7 January 2016

The national weather agency KNMI has issued Code Red for the three provinces Groningen, Friesland and Drenthe. Due to the continuing bad weather, current policies in the UMCG will Continue reading »

Glazed frost and its consequences for the UMCG on Campus

Towards a Man-Made Blue Zone in the Northern Netherlands, Are you in?

Tuesday 5 January 2016

The North must be the First Man-Made BlueZone of the world. That is the ambition of Daan Bultje, director of the Healthy Ageing Network Northern Netherlands (HANNN). The term Blue Continue reading »

Towards a Man-Made Blue Zone in the Northern Netherlands, Are you in?